140 related articles for article (PubMed ID: 30807702)
21. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
Kim SH; Singh KB; Hahm ER; Singh SV
Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
[TBL] [Abstract][Full Text] [Related]
22. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
23. Expression of microRNA-133 inhibits epithelial-mesenchymal transition in lung cancer cells by directly targeting FOXQ1.
Xiao B; Liu H; Gu Z; Ji C
Arch Bronconeumol; 2016 Oct; 52(10):505-11. PubMed ID: 26858166
[TBL] [Abstract][Full Text] [Related]
24. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
[TBL] [Abstract][Full Text] [Related]
25. FOXF2 deficiency permits basal-like breast cancer cells to form lymphangiogenic mimicry by enhancing the response of VEGF-C/VEGFR3 signaling pathway.
Wang QS; He R; Yang F; Kang LJ; Li XQ; Fu L; Sun B; Feng YM
Cancer Lett; 2018 Apr; 420():116-126. PubMed ID: 29409810
[TBL] [Abstract][Full Text] [Related]
26. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers.
Kundu ST; Byers LA; Peng DH; Roybal JD; Diao L; Wang J; Tong P; Creighton CJ; Gibbons DL
Oncogene; 2016 Jan; 35(2):173-86. PubMed ID: 25798833
[TBL] [Abstract][Full Text] [Related]
27. Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells.
Guo J; Yan Y; Yan Y; Guo Q; Zhang M; Zhang J; Goltzman D
Oncol Rep; 2017 Oct; 38(4):2003-2010. PubMed ID: 28791370
[TBL] [Abstract][Full Text] [Related]
28. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P
Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011
[TBL] [Abstract][Full Text] [Related]
29. MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.
Zhang T; Wan JG; Liu JB; Deng M
Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829888
[TBL] [Abstract][Full Text] [Related]
30. HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer.
Pantelaiou-Prokaki G; Mieczkowska I; Schmidt GE; Fritzsche S; Prokakis E; Gallwas J; Wegwitz F
Clin Epigenetics; 2022 Jan; 14(1):7. PubMed ID: 35016723
[TBL] [Abstract][Full Text] [Related]
31. Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer.
Dai J; Wang JY; Yang LL; Xiao Y; Qu ZL; Qin SH; Ruan QR
J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):896-901. PubMed ID: 25480587
[TBL] [Abstract][Full Text] [Related]
32. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
Dou C; Jin X; Sun L; Zhang B; Han M; Li T
Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850
[TBL] [Abstract][Full Text] [Related]
33. Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor.
Kong PZ; Yang F; Li L; Li XQ; Feng YM
PLoS One; 2013; 8(4):e61591. PubMed ID: 23620774
[TBL] [Abstract][Full Text] [Related]
34. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455
[No Abstract] [Full Text] [Related]
35. FOXF2 differentially regulates expression of metabolic genes in non-cancerous and cancerous breast epithelial cells.
Lo PK
Trends Diabetes Metab; 2018; 1(1):. PubMed ID: 30294731
[TBL] [Abstract][Full Text] [Related]
36. MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1.
Xiang XJ; Deng J; Liu YW; Wan LY; Feng M; Chen J; Xiong JP
Cell Physiol Biochem; 2015; 36(4):1382-94. PubMed ID: 26159618
[TBL] [Abstract][Full Text] [Related]
37. Unraveling the role of FOXQ1 in colorectal cancer metastasis.
Abba M; Patil N; Rasheed K; Nelson LD; Mudduluru G; Leupold JH; Allgayer H
Mol Cancer Res; 2013 Sep; 11(9):1017-28. PubMed ID: 23723077
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].
Wu WX; Zhang YP; Wen XW; Lu N; Tang ZY; Zhang Y; Wang Z; Wang W; Yang HJ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):519-23. PubMed ID: 20021961
[TBL] [Abstract][Full Text] [Related]
39. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A/MDM2 expression.
Zhang X; Wang L; Wang Y; Shi S; Zhu H; Xiao F; Yang J; Yang A; Hao X
Oncol Rep; 2016 Oct; 36(4):2349-56. PubMed ID: 27573292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
